Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO)

Historical Holders from Q4 2022 to Q3 2025

Symbol
OBIO on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
56,338,036
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,412,690
Holdings value
$55,584,342
% of all portfolios
0%
Number of holders
49
Number of buys
25
Number of sells
-32
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 15.4% -28.6% $22,260,249 8,306,063 0% RTW Investments, LP 04 Aug 2025
Medtronic plc 15.4% $14,848,357 5,868,916 Medtronic plc 31 Dec 2024
PERCEPTIVE ADVISORS LLC 9.99% $14,085,110 5,679,480 Perceptive Advisors LLC 30 Sep 2025
Tasso Partners, LLC 5.5% $7,684,508 3,098,592 Dana Lorenzo 15 Nov 2025
BlackRock, Inc. 3.7% $3,619,674 1,430,701 BlackRock, Inc. 31 Mar 2025

Institutional Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 22,412,690 $55,584,342 +$11,822,209 $2.48 49
2025 Q2 17,679,478 $47,383,339 -$3,869,274 $2.68 57
2025 Q1 18,991,589 $81,285,133 -$1,022,777 $4.28 55
2024 Q4 19,251,082 $77,005,657 -$602,359 $4.00 53
2024 Q3 19,025,849 $97,782,881 +$23,796,821 $5.14 47
2024 Q2 14,216,993 $115,871,788 +$7,254,151 $8.15 46
2024 Q1 13,334,624 $70,275,199 +$299,341 $5.27 42
2023 Q4 13,269,980 $121,156,215 +$1,621,325 $9.13 39
2023 Q3 13,093,349 $114,176,966 +$20,438,436 $8.72 42
2023 Q2 10,783,562 $75,485,512 +$5,117,242 $7.00 39
2023 Q1 9,872,658 $193,184,972 +$179,728,876 $19.57 22
2022 Q4 685,801 $6,851,000 +$6,851,000 $9.99 1